K
Konomi (Beijing) Technology
AI-powered diagnostics and analysis for healthcare
About Konomi (Beijing) Technology
Konomi (Beijing) Technology Co., Ltd., operating as Chromai, is a high-tech enterprise founded in 2019 that develops and produces analytical and testing instruments. The company is headquartered in Beijing, China, and focuses on integrating technologies like AI, Big Data, and IoT with advanced analytical detection methods. Its primary markets include in-vitro diagnostics (IVD) for the healthcare sector, environmental protection, and scientific instruments.
Chromai's product line features a range of high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (UHPLC) systems. These include the Voyager series, an automated two-dimensional liquid chromatography system for IVD that aims to simplify the diagnostic process for medical users. The company also offers the Frontier UHPLC system, the bio-inert Leaps Pro Bio system for analyzing biological molecules, and the more economical Leaps UHPLC system. By combining its hardware with AI, Chromai aims to provide simplified and efficient diagnostic and testing analysis.
Since its founding, Chromai has secured significant funding to support its growth. The company raised $14.2 million in an Early Stage Venture Capital round on June 5, 2023. Investors in the company include Huagai Capital, Tsing Stone Asset Management, Hongshan Capital Group, Suzhou Guofa Venture Capital, and YuanBio Venture Capital.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- China
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 72.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Medical & Healthcare, Core AI, Health Diagnostics, Techbio, DT and LS, science-based
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Feb 2026 | $2.8M | $69M | Beijing Medical and Health Industry Investment Fund | ↗ |
| SERIES A✓Equity / VC | Aug 2025 | $2.8M | $69M | Tianjin Jiuan Medical Electronics | ↗ |
Growth signals
Latest recorded traffic for Konomi (Beijing) Technology is 360 monthly website visits, up 125% over the last three months. Konomi (Beijing) Technology's team declined 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Yuansheng BioVenture
Huagai Capital- QCQingshi Capital
Tianjin Jiuan Medical Electronics- BFBeijing Medical and Health Industry Investment Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Konomi (Beijing) Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Konomi (Beijing) Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.